Advertisement

Topics

Sarepta, Genethon collaborate for Duchenne muscular dystrophy

11:00 EDT 21 Jun 2017 | CentreWatch

Sarepta Therapeutics, Inc., a U.S. commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare neuromuscular diseases, and Genethon, a non-profit R&D organization dedicated to the development of biotherapies for orphan genetic diseases from research to clinical validation, have signed a gene therapy research collaboration to jointly […]

The post Sarepta, Genethon collaborate for Duchenne muscular dystrophy appeared first on CenterWatch News Online.

Original Article: Sarepta, Genethon collaborate for Duchenne muscular dystrophy

NEXT ARTICLE

More From BioPortfolio on "Sarepta, Genethon collaborate for Duchenne muscular dystrophy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...